Air Cleaners for Children and Adolescents With Asthma and Dog Allergy
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose is to find out if Icleen IQAir, HEPA-filter air cleaners with high capacity and pre-set speed functions, have a beneficial effect on patients with asthma and allergy to dogs.
Air cleaners will be installed in the bedrooms and living rooms in the homes of children and adolescents aged 8-17 years at the study entry, with allergy to dogs, but not to house dust mites.
The investigators will look upon the significance of this study, and of a previous study with a similar design and the same main parameters to find out if this trial supports the results of the first trial by the same project leader, or makes it likely that the seemingly beneficial effects of the first study occurred by chance.
Main parameters:
- hyperventilation cold air challenge test
Supportive parameters:
- serum ECP
- symptom scores
The trial will be a parallel, double blind placebo controlled one.
| Condition | Intervention |
|---|---|
|
Asthma Allergy |
Device: IQAir Allergen 100 Air cleaners |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator) Primary Purpose: Treatment |
| Official Title: | Air Cleaners for Children and Adolescents With Asthma and Dog Allergy |
- Bronchial hyperactivity by cold air hyperventilation [ Time Frame: September 2005 - February 2006 ] [ Designated as safety issue: No ]
- Serum ECP [ Time Frame: September 2005- February 2006 ] [ Designated as safety issue: No ]
- Asthma symptom score [ Time Frame: September 2005 - February 2006 ] [ Designated as safety issue: No ]
- Allergic rhinitis symptom score [ Time Frame: September 2005 - February 2006 ] [ Designated as safety issue: No ]
| Enrollment: | 22 |
| Study Start Date: | September 2005 |
| Study Completion Date: | April 2006 |
| Primary Completion Date: | February 2006 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Active air cleaner
Two Icleen IQAir air cleaners with active filters supplied
|
Device: IQAir Allergen 100 Air cleaners
Two air cleaners are installed in the patient's room, one in his bedroom, and one in the living room. The cleaners can be run at 5 different speeds: Speed 1 filtrates 60m3 of air per hour, speed 2 filtrates 90 m3 per hour, speed 3 filtrates 130 m3 per hour, speed 4 filtrates 240 m3 per hour, and speed 5 filtrates 380 m3 per hour. A timer-on period can be pre-set for every day of the week, but the cleaner can be run even in the timer-off period, at a speed pre-set and different from the timer-on period. Different timer-on off periods cannot be selected for different days, but the different days of the week can be pre-set to apply timer-on periods or not.
Other Name: Health Pro
|
|
Placebo Comparator: Placebo air cleaner
Two Icleen IQAir air cleaners with placebo filters supplied
|
Device: IQAir Allergen 100 Air cleaners
Two air cleaners are installed in the patient's room, one in his bedroom, and one in the living room. The cleaners can be run at 5 different speeds: Speed 1 filtrates 60m3 of air per hour, speed 2 filtrates 90 m3 per hour, speed 3 filtrates 130 m3 per hour, speed 4 filtrates 240 m3 per hour, and speed 5 filtrates 380 m3 per hour. A timer-on period can be pre-set for every day of the week, but the cleaner can be run even in the timer-off period, at a speed pre-set and different from the timer-on period. Different timer-on off periods cannot be selected for different days, but the different days of the week can be pre-set to apply timer-on periods or not.
Other Name: Health Pro
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 8 Years to 17 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Children and adolescents between 8 and 17 years of age at the start of the trial (born after 01 March '88, but before 01 September '97).
- Bronchial asthma, diagnosed by a physician, and confirmed by a physician at a paediatric department of a Norwegian Hospital.
- Allergy against dogs, confirmed by skin prick test. Average infiltrate at least 4 millimetres against dog, diagnosed by a new skin prick test at entry. For details about skin prick test, see attachment no. 6.
- Having had nose or breathing symptoms by contact with dogs, when no drugs against asthma or allergy have been taken.
- Able to co-operate at cold air hyperventilation test and spirometry (see attachment no. 2).
- Given written consent (by parents of children below 12; by parents and child when above 12, but below 16; by patient when above 16).
Exclusion Criteria:
- Positive house dust mite skin prick test, with a more than 3 mm infiltrate.
- Having taken oral beta-2-agonists or theophylline preparations for the last 2 weeks before trial start, or oral steroids for the last 3 months before start of the trial.
- Active smoking.
- Dogs or cats in the home.
- Staying away from the home continuously for more than 14 days in the trial period or during the last month before trial start.
- Being an in-patient in a special department or institution for asthma and allergy in the trial period or the last 3 months before the trial.
- Having another chronic disease that can influence the results of ECP or cold air hyperreactivity tests.
- Other types of mechanical ventilation or air filtration systems in the homes, except for those for kitchen stoves.
Contacts and Locations| Norway | |
| Barnepoliklinikken, Sykehuset Innlandet HF | |
| Hamar, Norway, N-2326 | |
| Principal Investigator: | Leif B. Rolfsjord, M.D. | Sykehuset Innlandet HF |
| Study Chair: | Leiv Sandvik, PhD | Oslo Universitetssykehus Ulleval |
| Study Chair: | Ragnhild Halvorsen, M.D., Ph.D. | Oslo Universitetssykehus Rikshospitalet |
| Study Chair: | Sten Dreborg, M.D., Ph.D. | Alingsåsv. 11, S-443 35 Lerum, Sweden |
More Information
Publications:
| Responsible Party: | Leif Bjarte Rolfsjord/ seksjonsoverlege, Sykehuset Innlandet HF |
| ClinicalTrials.gov Identifier: | NCT00220753 History of Changes |
| Other Study ID Numbers: | AIR CLEANER TRIAL 2 SIHF, PARTIAL SPONSOR INCEN AG |
| Study First Received: | September 19, 2005 |
| Last Updated: | July 21, 2009 |
| Health Authority: | Norway: Norwegian Social Science Data Services Norway: Directorate of Health |
Keywords provided by Sykehuset Innlandet HF:
|
Dog allergy Pet allergy Air cleaners HEPA filters Air filtration Can f1 |
Asthma Children Adolescents Indoor environment Indoor allergy Perennial allergy |
Additional relevant MeSH terms:
|
Hypersensitivity Asthma Immune System Diseases Bronchial Diseases Respiratory Tract Diseases |
Lung Diseases, Obstructive Lung Diseases Respiratory Hypersensitivity Hypersensitivity, Immediate |
ClinicalTrials.gov processed this record on May 19, 2013